FDA approval brings Enhertu into early breast cancer treatment, boosting response before surgery and cutting recurrence risk ...
The U.S. Food and Drug Administration has approved AstraZeneca's Enhertu (fam-trastuzumab deruxtecan-nxki) for both the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results